Most Read Articles
23 Oct 2017
Pearl Toh spoke with Dr Teh Ming Ming, senior consultant at the Department of Endocrinology, Singapore General Hospital (SGH), on the major challenges of diagnosing and managing diabetes in primary care, in conjunction with the World Diabetes Day on 14 November. Awareness of the symptoms of diabetes is important, and patients should be empowered to manage their conditions.
Jairia Dela Cruz, 20 Jan 2018
Empagliflozin appears to be beneficial to type 2 diabetes (T2D) patients with established cardiovascular disease (CVD) and chronic kidney disease (CKD), yielding reductions in CV and all-cause mortality, as well as in heart failure and all-cause hospitalization compared with placebo, according to a study.
13 Feb 2018
Short-term treatment with methotrexate at >0.5 defined daily dose (8.75 mg/week) may help reduce the risk of ischaemic stroke in rheumatoid arthritis (RA) patients, while hydroxychloroquine and sulfasalazine have neutral effects, a retrospective study has found.
01 Nov 2015
Pharmacy-led protocol for vancomycin dosing achieves better therapeutic levels and less renal failure development, as shown in a study.

Younger children more prone to experience behavioural side effects of AED

29 Nov 2017

Younger children appear to be more likely to experience behavioural side effects of antiepileptic drugs (AEDs), with the likelihood increasing if children with epilepsy have baseline hyperactivity/impulsivity, a retrospective study has found.

A total of 380 youths (mean age 8.9 years; 83.4 percent Caucasian) with new-onset epilepsy were included in the study. The Behavior Assessment System for Children, 2nd Edition: Parent Rating Scale and the Pediatric Epilepsy Side Effects Questionnaire were completed by the youths’ caregivers to obtain data on psychological functioning at baseline and identify AED behavioural side effects at the 1-month follow-up following AED initiation. Children (aged 2 to 11 years) and adolescents (aged 12 to 18 years) were separately evaluated.

In the population, 34.8 percent had focal epilepsy, 41.1 percent had generalized epilepsy and 23.7 percent had unclassified epilepsy. Majority (70 percent) had at-risk or clinically elevated baseline psychological symptoms.

Behavioural side effects of AEDs occurred with greater frequency in children than in adolescents (25.08 vs 12.36), regardless of the drug used. Valproic acid was associated with significantly greater behavioural side effects compared with all other AEDs, except for levetiracetam.

In both age groups, higher hyperactivity/impulsivity at baseline emerged as significant predictor of higher behavioural side effects 1 month after AED initiation.

The present data show that AED tolerability is better among older than younger children, with valproic acid being a more challenging AED across the age spectrum, researchers pointed out, adding that baseline psychological screening, specifically hyperactivity, can be used as a precision medicine tool for AED selection.

“When baseline psychological symptoms are present, particularly hyperactivity/impulsivity, providers may consider avoiding AEDs with greater potential for psychotropic effects to increase tolerability for the patient and family early in the course of treatment, along with decreasing the need for multiple AED trials due to problematic side effects. If unavoidable, caregivers may benefit from anticipatory guidance on managing behavioural side effects,” researchers said.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Pharmacy - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
23 Oct 2017
Pearl Toh spoke with Dr Teh Ming Ming, senior consultant at the Department of Endocrinology, Singapore General Hospital (SGH), on the major challenges of diagnosing and managing diabetes in primary care, in conjunction with the World Diabetes Day on 14 November. Awareness of the symptoms of diabetes is important, and patients should be empowered to manage their conditions.
Jairia Dela Cruz, 20 Jan 2018
Empagliflozin appears to be beneficial to type 2 diabetes (T2D) patients with established cardiovascular disease (CVD) and chronic kidney disease (CKD), yielding reductions in CV and all-cause mortality, as well as in heart failure and all-cause hospitalization compared with placebo, according to a study.
13 Feb 2018
Short-term treatment with methotrexate at >0.5 defined daily dose (8.75 mg/week) may help reduce the risk of ischaemic stroke in rheumatoid arthritis (RA) patients, while hydroxychloroquine and sulfasalazine have neutral effects, a retrospective study has found.
01 Nov 2015
Pharmacy-led protocol for vancomycin dosing achieves better therapeutic levels and less renal failure development, as shown in a study.